PDUFA Date

Related by string. PDUFA date * : assigned PDUFA . PDUFA Prescription Drug . Act PDUFA guidelines . PDUFA reauthorization . PDUFA . Act PDUFA / dates . Dates . DATES . DATE . - Date [002] . - Date [003] . - Date [001] : Tour Dates Announced . Non Brokered BULLETIN DATE . Release Date Announced . Early Tender Date . candi dates . Release Date Confirmed . EQUITIES Date GMT * Act PDUFA date *

Related by context. Frequent words. (Click for all words.) 80 Generic Version 77 FDA Accepts 76 Patient Enrollment 74 Phase III Clinical Trial 74 Pivotal Trial 73 Drug Candidate 73 Clinical Trial Results 73 Cholesterol Drug 73 Single Dose 72 Pivotal Phase III 71 Extended Release 71 Pivotal Phase 71 Initiate Phase 70 Positive Opinion 70 Phase III Trial 70 Transcept Pharmaceuticals 70 Act PDUFA date 69 Anika Therapeutics 69 Marketing Authorisation 69 Pivotal Study 69 BioDelivery Sciences 69 Blood Thinner 69 Complete Response 69 Preclinical Data 68 Low Dose 68 Pulmonary Arterial Hypertension 68 Cervical Cancer Vaccine 68 Oral Solution 68 Clinical Trials Update 67 Completes Enrollment 67 FDA Advisory Panel 67 Prostate Cancer Patients 67 Recombinant Human 67 FDA Clears 67 FDA Clearance 67 Delayed Release 67 Somaxon Pharmaceuticals 67 Presents Positive 67 Initiates Phase II 66 Diet Pill 66 Ambrisentan 66 Smallpox Vaccine 66 Product Characteristics 66 Extended Release Tablets 66 Metastatic Melanoma 66 OSI Pharma 66 ZEGERID Capsules 66 Halozyme Therapeutics 66 Cethromycin 66 Eltrombopag 66 Pirfenidone 66 RNAi Therapeutics 65 II Clinical Trial 65 FDA Orphan Drug 65 Release Tablets 65 Metabasis Therapeutics 65 FDA Complete Response 65 Monotherapy 65 Golimumab 65 Patent Covering 65 Drug Application 65 Patent Lawsuit 65 Pediatric Patients 65 Boceprevir 65 FY# Guidance 65 Commences Phase 65 ACADIA Pharmaceuticals 64 Levofloxacin 64 FDA approvable letter 64 Panzem R 64 Orphan Drug Status 64 #mg #mg [002] 64 Dasatinib 64 Ranexa R 64 Aliskiren 64 Stock Repurchase Plan 64 Advanced Prostate Cancer 64 Emisphere Technologies 64 FDA Approval 64 Cold Medicines 64 Full Prescribing Information 64 Develop Novel 64 Cyclacel Pharmaceuticals 64 NOXAFIL 64 Renal Cell Carcinoma 64 TYGACIL 64 Protalix BioTherapeutics 64 Marketing Authorization Application 64 Announces FDA Clearance 64 Patent Infringement Lawsuit 64 Bevacizumab 64 Tacrolimus 64 Lung Cancer Patients 63 Option Grants 63 Boxed Warning 63 Application MAA 63 Pfizer Lyrica 63 Annual Meeting Date 63 Benign Prostatic Hyperplasia 63 Drug Submission 63 Vfend

Back to home page